KKR in talks to buy India’s SRL

MUMBAI: KKR & Co is in advanced talks to buy a stake in medical-diagnostics company SRL Ltd, said sources. The deal could value SRL at about 50 billion rupees (RM3.4 billion), said sources. Private equity firms including TPG and Bain Capital were also in talks for a stake in the firm, said sources last month. The diagnostics company is being spun off from Fortis Healthcare Ltd. Majority shareholders of Fortis, brothers Malvinder Singh and Shivinder Singh, will control a 40.6 per cent stake of SRL when it is listed, according to an exchange filing in August.